Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis
about
Diet and relapsing ulcerative colitis: take off the meat?Mitochondrial dysfunction in inflammatory bowel diseaseRadical induction theory of ulcerative colitisHydrogen sulphide: a bacterial toxin in ulcerative colitis?Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugsThe role of the colonic flora in maintaining a healthy large bowel mucosaThe role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in ratsA simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopic biopsy specimens. Comparison of isolation methods, assessment of viability and metabolic activity.Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa.A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon.Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production.Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease.Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.The function of our microbiota: who is out there and what do they do?Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis.Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiotaReview article: lactose--a potential prebiotic.Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.Intestinal microflora as a therapeutic target in inflammatory bowel disease.Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human fecesApoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epitheliumThe contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitisIn vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitisStat3: friend or foe in colitis and colitis-associated cancer?Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitisPropionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseasesEffects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences.Analysis of bacterial bowel communities of IBD patients: what has it revealed?Importance of nutrition in inflammatory bowel disease.Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.Claudin-3 and occludin content in the glands of colonic mucosa devoid from fecal stream submitted to topical intervention with oil extract of Curcuma longa.Perspectives on tight junction research.Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation.Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity.Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.Effects of short-chain fatty acids on the inflamed colonic mucosa.Oxidation of short and medium chain C2-C8 fatty acids in Sprague-Dawley rat colonocytes
P2860
Q24685815-2630D251-A0F3-4326-90F5-B5C860B32D1CQ26781311-1636DA98-C6C3-44BA-AE19-DA5F977D8F2FQ28245348-D53B3FF6-590E-442E-8941-07FF069F3D5BQ28294163-A3324118-4B07-4C07-823A-D8E54DC7D7C5Q28360107-CC160848-B40E-44A3-935A-6623A63E5E62Q28363588-464C2A70-6F8C-43EE-A089-BD4E71839C99Q28538671-877F4ED1-F9F5-468C-B20E-C33ACDE8D06BQ30917519-65F5023F-FA45-4CC5-AA34-84ECE0D0CFC0Q33859570-ABD2D0B4-CF86-48FA-B7BB-6EF059747EE6Q34099033-9ED45123-8657-4D8B-BB10-7004A343CB0CQ34118618-4361FD60-E58A-43B7-86BF-C7AC58C701ADQ34151794-10221003-5200-4225-969B-3F881903D098Q34193433-EE66CFC6-6BBF-404B-B950-171204751ED3Q34392557-9D2F2040-A366-42A9-B5BD-FA27AC57BF7CQ34408315-89855644-E58F-431D-9521-F928A6D47542Q34408893-66CAE38E-C4EB-42A1-B1CE-E05619005E16Q34409826-C3A5406E-BA31-485A-82C5-E5B67F966F32Q34778107-0B3914FF-B45F-4FE5-A55F-3E3EEA8CF11FQ34799355-4543A9D5-8F94-40DB-A26A-F240BB6FB175Q34900690-ABD74B06-3A75-45DB-BD21-765C08540427Q35062098-352ADC49-6C1A-4C53-843B-D756E614CC69Q35154979-B0A50615-C652-4284-B8BE-D1C6E0710313Q35350093-7463F61E-5C16-445C-A448-139177E7769CQ35358530-9FE81695-0C18-42F0-9BD2-CE3FBD82B410Q35358549-82A52669-7C9B-499A-A691-F0698C9A3713Q35596933-D7A56615-6784-4EA2-B980-39E9E36FF0C6Q36172749-81B168A1-7740-449F-BD95-0A1010FF9119Q36285788-0F0FDFF2-54FD-49D8-8B52-B9118497464FQ36674023-4F2555A6-45D7-4D5A-85BD-9B530845D748Q37084765-F3337D42-7B1F-4E3A-A5B7-6491938219BFQ37182945-29AEA3CB-3D28-4938-A20E-55D96C1F18C8Q37602088-8936D0C9-0D89-4243-A14C-A01C467853D0Q37973313-695BA2DB-C613-4944-833C-DC5C9573060AQ38948064-BCBD11F8-4F3F-41DE-9BA0-3B26E0E18700Q39607231-1F18401C-115F-4DD9-812C-2D0EB73ED200Q40260142-0FEEDDCB-965A-4BEC-BFA7-213E62B9AE8CQ40770003-D4D287A8-FE7F-4035-80C3-3216A801BD99Q40778493-02EB38CA-E6F7-4017-A181-CABC30857E2BQ41466103-1CE82F46-BA66-4CEB-B142-62555AB6E853Q42109135-7C189630-00F8-46E0-9DEC-2F4C5D1B914F
P2860
Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@ast
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@en
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@nl
type
label
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@ast
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@en
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@nl
prefLabel
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@ast
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@en
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@nl
P2093
P2860
P356
P1433
P1476
Butyrate oxidation is impaired ...... f quiescent ulcerative colitis
@en
P2093
P2860
P356
10.1136/GUT.35.1.73
P407
P577
1994-01-01T00:00:00Z